<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Cholera: Epidemiology, clinical features, and diagnosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Cholera: Epidemiology, clinical features, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Cholera: Epidemiology, clinical features, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Regina LaRocque, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jason B Harris, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Stephen B Calderwood, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Elinor L Baron, MD, DTMH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 18, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H938291586"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cholera is a life-threatening diarrheal illness caused by cholera toxin-producing strains of <em>Vibrio cholerae</em>.</p><p>Issues related to the epidemiology, microbiology, clinical manifestations, and diagnosis of cholera will be reviewed here. Issues related to treatment and prevention of cholera are discussed separately. (See  <a class="medical medical_review" href="/d/html/141337.html" rel="external">"Cholera: Treatment and prevention"</a>.)</p><p>Issues related to infections caused by non-O1/O139 <em>V. cholerae</em> strains are discussed separately. (See  <a class="medical medical_review" href="/d/html/3145.html" rel="external">"Infections due to non-O1/O139 Vibrio cholerae"</a>.)</p><p>The general approaches to acute diarrhea among adults and children in resourced-limited settings are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a>.)</p><p class="headingAnchor" id="H3241815506"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H3770955150"><span class="h2">Etiologic agent</span><span class="headingEndMark"> — </span><em>Vibrio cholerae</em> is a highly diverse species with more than 200 serologic groups, including pathogenic and non-pathogenic variants. The disease cholera is caused by cholera toxin-producing (toxigenic) strains of <em>V. cholerae</em>, which are in serogroups O1 and O139 [<a href="#rid1">1</a>]. </p><p>Toxigenic strains harbor the bacteriophage CTXΦ, which encodes cholera toxin [<a href="#rid2">2</a>]. <em>V. cholerae</em> can evolve rapidly through acquisition of mobile genetic elements. (See <a class="local">'Mechanism of infection'</a> below.)</p><p><em>V. cholerae</em> has a distinctive appearance; it is a comma-shaped gram-negative rod; the organisms are highly motile and possess a single polar flagellum. </p><p class="headingAnchor" id="H2715680502"><span class="h2">Classification</span><span class="headingEndMark"> — </span><em>V. cholerae</em> is classified based on differences in the structure of the O antigen of its lipopolysaccharide. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serogroup O1</strong> – <em>V. cholerae </em>O1 is divided into two major serotypes, Inaba and Ogawa; these differ by the presence of a single methyl group on the Ogawa O-specific polysaccharide antigen [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1"><em>V. cholerae</em> O1 is also divided into two biotypes, El Tor and classical; these are differentiated by biochemical distinctions and susceptibility to specific bacteriophages. Previous <em>V. cholerae</em> pandemics were caused by the classical biotype, which is now thought to be extinct [<a href="#rid4">4</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serogroup O139</strong> – <em>V. cholerae</em> O139 emerged in 1992 and was an important cause of epidemic cholera for a decade, but is no longer a major cause of cholera [<a href="#rid4">4,5</a>].</p><p></p><p class="headingAnchor" id="H1982807423"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H2939472644"><span class="h2">Transmission</span><span class="headingEndMark"> — </span><em>Vibrio cholerae</em> is transmitted via the fecal-oral route; this includes transmission within households or between close contacts, as well as outbreaks related to contaminated food and water. In endemic regions, <em>V. cholerae</em> in the water are an important reservoir of the organism; <em>V. cholerae</em> can live on chitinous plankton [<a href="#rid6">6</a>]. </p><p>The infectious dose of <em>V. cholerae</em> required to cause cholera is thought to be relatively high; an inoculum of 10<sup>8</sup> <em>V. cholerae</em> or higher resulted in severe infection among healthy volunteers [<a href="#rid7">7,8</a>]. </p><p>Individuals with severe cholera excrete as many as 10<sup>10</sup> to 10<sup>12</sup> organisms per liter of stool. Recently shed organisms may be more infectious than organisms from the aquatic environment [<a href="#rid9">9,10</a>]. </p><p>Issues related to preventing transmission are discussed separately. (See  <a class="medical medical_review" href="/d/html/141337.html" rel="external">"Cholera: Treatment and prevention", section on 'Preventing transmission'</a> and  <a class="medical medical_review" href="/d/html/141337.html" rel="external">"Cholera: Treatment and prevention"</a>.)</p><p class="headingAnchor" id="H751547859"><span class="h2">Risk factors</span><span class="headingEndMark"> — </span>Cholera is associated with people whose incomes are below federal poverty thresholds and lack of access to safe food, water, and adequate sanitation [<a href="#rid11">11,12</a>]. Large cholera epidemics often occur in populations impacted by natural disaster or human conflict [<a href="#rid13">13</a>]. </p><p>In some foodborne cholera outbreaks, risk factors may include consumption of specific foods, including rice products or certain fruits or vegetables [<a href="#rid14">14</a>]. In areas where cholera occurs sporadically, most cases are associated with shellfish consumption.</p><p>Host-based factors influencing risk for <em>V. cholerae </em>infection include [<a href="#rid15">15</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Blood group O has been associated with more severe illness [<a href="#rid16">16-18</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with hypochlorhydria or partial gastrectomy, a lower infectious dose is needed to cause infection [<a href="#rid19">19,20</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prior infection is protective against subsequent infection; however, protection is serogroup specific [<a href="#rid21">21-23</a>].</p><p></p><p>Breastfeeding of young infants has been shown to be protective against cholera [<a href="#rid15">15,24</a>]. </p><p class="headingAnchor" id="H686408840"><span class="h2">Mechanism of infection</span><span class="headingEndMark"> — </span>For infection to occur, <em>V. cholerae</em> must survive the acidic environment of the stomach, then attach to the small intestine and produce cholera toxin. </p><p>Cholera toxin is the main virulence factor of pathogenic <em>V. cholerae</em> strains; it activates an intracellular pathway resulting in massive fluid secretion into the small intestine, leading to large volumes of fluid loss with high concentrations of sodium, chloride, bicarbonate, and potassium [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H938291613"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H721401625"><span class="h2">Global distribution</span><span class="headingEndMark"> — </span>Each year, there are an estimated 3 million cases of diarrheal illness and approximately 100,000 deaths worldwide caused by <em>Vibrio cholerae</em> [<a href="#rid26">26</a>]. However, cholera is vastly underreported, and precise measurements of attributable morbidity and mortality are lacking. </p><p>Cholera occurs primarily in settings where there is inadequate access to clean water and sanitation; it occurs endemically as well as epidemically (see <a class="local">'Endemic versus epidemic infection'</a> below):</p><p class="bulletIndent1"><span class="glyph">●</span>Cholera is endemic in approximately 50 countries (defined as having reported cholera cases in at least three of the five past years), mostly in Africa and Asia [<a href="#rid26">26,27</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Epidemics due to <em>V. cholerae</em> have occurred throughout Africa, Asia, the Middle East, South and Central America, and the Caribbean [<a href="#rid28">28</a>]. Epidemics can span a broad geographic area; as an example, the strain implicated in the 2010 outbreak in Haiti was subsequently associated with outbreaks in the neighboring countries of Dominican Republic, Cuba, and Mexico [<a href="#rid29">29</a>]. </p><p></p><p>Cases in resource-abundant settings are generally imported from travel to endemic or epidemic settings [<a href="#rid30">30</a>].</p><p class="headingAnchor" id="H595191151"><span class="h2">Endemic versus epidemic infection</span><span class="headingEndMark"> — </span>Patterns of cholera transmission and infection differ between endemic areas and areas experiencing epidemics. </p><p>In areas of high endemicity, the incidence of <em>V. cholerae</em> infection follows a seasonal distribution, with peaks before and after rainy seasons [<a href="#rid28">28</a>]. Superimposed epidemics may also occur; mathematical models suggest these epidemics are dependent on fluctuations in population-based immunity and climate [<a href="#rid31">31</a>]. In areas of high endemicity, the incidence of cholera is highest among children &lt;5 years of age, likely reflecting lack of protective immunity [<a href="#rid32">32</a>].</p><p>In areas with limited population immunity, massive epidemics may occur, with similar attack rates among children and adults. As an example, during the 2010 cholera epidemic in Haiti, a <em>V. cholerae</em> O1 variant El Tor strain was introduced from South Asia [<a href="#rid33">33,34</a>]. Within two years, 604,634 cases of infection, 329,697 hospitalizations, and 7436 deaths from cholera were reported in Haiti [<a href="#rid35">35</a>]. A reactive vaccination campaign was credited with reducing cholera transmission in Haiti; no cases of cholera occurred between 2019 and 2022. However, the same <em>V. cholerae</em> strain reemerged in September 2022 [<a href="#rid36">36</a>]. During this reemergence, a higher burden of disease has been observed among young children, likely reflecting lack of protective immunity [<a href="#rid37">37</a>].</p><p>Even in endemic regions, breakdowns in safe water, hygiene, and health services can contribute to epidemic transmission of cholera. In Yemen, where public health and healthcare infrastructure have been devastated by years of warfare, two outbreaks occurred in short succession at the end of 2016 and the middle of 2017. During the second outbreak, approximately 500,000 cases and 2000 associated fatalities were recorded within four months [<a href="#rid38">38</a>]. </p><p>Other major outbreaks have occurred in numerous countries. In 2022, 16 countries reported protracted cholera outbreaks [<a href="#rid39">39</a>]. Fatality rates in the setting of epidemic cholera are consistently &gt;1 percent, particularly in rural areas and in the early stages of an epidemic [<a href="#rid40">40</a>]. As an example, in the 2008 to 2009 cholera outbreak in Zimbabwe which involved nearly 100,000 people, the case fatality rate was &gt;4 percent [<a href="#rid41">41</a>].</p><p class="headingAnchor" id="H101228018"><span class="h2">Cholera pandemics</span><span class="headingEndMark"> — </span>Over the last two centuries there have been seven pandemics of <em>V. cholerae</em> [<a href="#rid28">28</a>]<em>.</em> <em>V. cholerae</em> O1 El Tor is the cause of the current, seventh pandemic. This pandemic represents the expansion of a single bacterial lineage with a common ancestral clone dated to 1952 [<a href="#rid4">4</a>]. </p><p>The current pandemic has been comprised of three independent waves of transmission; each has coincided with acquisition of new genetic material conferring enhanced environmental stability, drug resistance, or virulence to the previously circulating strains of <em>V. cholerae </em>[<a href="#rid4">4</a>]. Each wave of transmission originated in South Asia before spreading to distant locations throughout Asia, Africa, South America, and the Caribbean. </p><p class="headingAnchor" id="H938291631"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span><em>Vibrio cholerae</em> infection is associated with a spectrum of manifestations ranging from asymptomatic intestinal colonization to severe diarrhea [<a href="#rid42">42</a>]. </p><p class="headingAnchor" id="H15278770"><span class="h2">Incubation period</span><span class="headingEndMark"> — </span>The typical incubation period is one to two days [<a href="#rid43">43-45</a>]; however, it can range from several hours to as long as three to five days. Factors influencing the incubation period include host susceptibility and inoculum size. </p><p class="headingAnchor" id="H928229880"><span class="h2">Signs and symptoms</span><span class="headingEndMark"> — </span>The clinical manifestations of cholera caused by <em>V. cholerae</em> O1 versus O139 are indistinguishable.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal symptoms </strong>–<strong> </strong>Vomiting may begin before or after onset of diarrhea. Patients may have abdominal cramping but usually do not have frank abdominal pain typically associated with dysentery. In early illness, cholera stools may contain fecal matter and bile [<a href="#rid28">28</a>]. Fever is uncommon; presence of fever should prompt evaluation for concurrent infection.</p><p></p><p class="bulletIndent1">Severe cholera ("cholera gravis") is characterized by passage of profuse "rice-water" stool, a watery stool with flecks of mucous  (<a class="graphic graphic_picture graphicRef93210" href="/d/graphic/93210.html" rel="external">picture 1</a>). It typically has a fishy odor. The diarrhea is usually painless, without tenesmus. </p><p></p><p class="bulletIndent1">Approximately 5 to 10 percent of patients develop severe hypovolemia [<a href="#rid1">1</a>]. In children with severe cholera, stool output is typically between 10 and 20 mL/kg per hour [<a href="#rid46">46</a>]. In adults with severe cholera, stool output can be as high as 1000 mL per hour. The total volume loss over the course of illness may be up to 100 percent of body weight [<a href="#rid47">47</a>]. Stool from patients with cholera contains a higher concentration of sodium than stool from patients with other causes of diarrheal illness  (<a class="graphic graphic_table graphicRef93208" href="/d/graphic/93208.html" rel="external">table 1</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Manifestations of hypovolemia and electrolyte loss</strong> – Severe cholera is associated with rapid development of hypovolemic shock due to profound fluid and electrolyte losses, often within hours of the symptom onset. Among patients who died before presentation to a cholera treatment center during the early stages of the Haiti 2010 cholera epidemic, the median time between symptom onset and death was 12 hours [<a href="#rid48">48</a>]. </p><p></p><p class="bulletIndent1">Patients with severe hypovolemia may have sunken eyes, dry mouth, cold clammy skin, decreased skin turgor, and wrinkled hands and feet ("washer woman's hands")  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 2</a>). Patients are frequently apathetic and lethargic. Kussmaul breathing (deep respirations reflecting compensatory hyperventilation) may occur due to acidosis from loss of stool bicarbonate as well as lactic acidosis from poor perfusion. Initially the pulse is rapid and thready; as the blood pressure drops, the pulse may become difficult to palpate. Muscle cramping and weakness due to loss of potassium and calcium are common. </p><p></p><p class="bulletIndent1">Laboratory testing may demonstrate hypokalemia, hyponatremia or hypernatremia (although cholera is most often associated with isonatremic dehydration), hypocalcemia, hypoglycemia, and acidosis.</p><p></p><p class="bulletIndent1">Renal failure with acute tubular necrosis may occur. In children, depletion of glycogen stores and inadequate gluconeogenesis can lead to symptoms of severe hypoglycemia or coma. </p><p></p><p class="headingAnchor" id="H595191434"><span class="h2">Complications</span></p><p class="bulletIndent1"><span class="glyph">●</span>The most important complication of cholera is hypovolemia and electrolyte loss, discussed above.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pneumonia (potentially from aspiration in the setting of vomiting) is an important complication of cholera among children. In one study including 33 patients who died of cholera, pneumonia accounted for two-thirds of deaths [<a href="#rid49">49</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chronic enteropathy and malnutrition may develop among children &lt;5 years of age [<a href="#rid1">1</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pregnant patients with cholera are at increased risk of miscarriage, premature delivery, and stillbirth [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>"Cholera sicca" is an unusual form of the cholera in which fluid accumulates in the intestinal lumen; circulatory collapse and death can occur in the absence of diarrhea.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacteremia due to <em>V. cholera</em> is rare. </p><p></p><p class="headingAnchor" id="H938291637"><span class="h1">DIAGNOSIS</span></p><p class="headingAnchor" id="H1887294171"><span class="h2">When to suspect cholera</span><span class="headingEndMark"> — </span>Cholera is a potential cause of severe watery diarrhea (with or without vomiting), especially in patients who develop rapid and severe volume depletion  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 2</a>). </p><p>According to the World Health Organization (WHO) definition for cholera reporting, cholera should be suspected in the following circumstances [<a href="#rid51">51-53</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>In areas where a cholera outbreak has not been declared: any person age ≥2 years presenting with acute watery diarrhea (AWD; defined as ≥3 loose or watery, non-bloody stools within a 24-hours period) and severe dehydration or dying from AWD.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Once a cholera outbreak has been declared: any person presenting with or dying from AWD.</p><p></p><p class="bulletIndent1">In children, volume-depleting diarrhea may be attributable to several pathogens; in adults, volume-depleting diarrhea is usually attributable to <em>Vibrio cholerae</em>. (See  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings"</a> and  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings"</a>.)</p><p></p><p>In resource-abundant settings where cholera is rare, epidemiologic clues that might raise suspicion of <em>V. cholerae</em> in a patient with acute watery diarrhea include travel to an area where cholera is present or ingestion of undercooked or raw shellfish. </p><p class="headingAnchor" id="H2823215107"><span class="h2">Clinical and diagnostic evaluation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical evaluation</strong> – Patients with suspected cholera should undergo careful assessment for signs and symptoms of volume depletion  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/13954.html" rel="external">"Approach to the adult with acute diarrhea in resource-limited settings", section on 'Clinical assessment'</a> and  <a class="medical medical_review" href="/d/html/13956.html" rel="external">"Approach to the child with acute diarrhea in resource-limited settings", section on 'Diagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent1">These findings are important for guiding initial management. (See  <a class="medical medical_review" href="/d/html/141337.html" rel="external">"Cholera: Treatment and prevention"</a> and <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Establishing a diagnosis </strong>– In most cases, cholera is diagnosed presumptively in patients with severe acute watery diarrhea. However, there are no signs or symptoms that can unequivocally distinguish cholera from other infectious causes  (<a class="graphic graphic_table graphicRef86525" href="/d/graphic/86525.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 4</a>). </p><p></p><p class="bulletIndent1">The diagnosis of cholera can be confirmed by isolation <em>of V. cholerae</em> from stool cultures performed on specific selective media. In settings where stool culture is not readily available, rapid tests such as stool dipsticks or darkfield microscopy can support the diagnosis. (See <a class="local">'Diagnostic tools'</a> below.)</p><p></p><p>Routine laboratory testing is not required. In patients with ileus, confusion, seizure, or no urine output in response to fluid replacement, serum electrolyte, and glucose testing may be useful to guide further management. </p><p class="headingAnchor" id="H682183435"><span class="h2">Diagnostic tools</span></p><p class="headingAnchor" id="H682183441"><span class="h3">Stool culture</span><span class="headingEndMark"> — </span>A definitive diagnosis of cholera is based on culture of the organism from a clinical sample (such as stool or rectal swab). <em>V. cholerae</em> can be isolated from stool using selective media such as thiosulfate citrate bile sucrose agar or taurocholate tellurite gelatin agar. Once cultured,<em> V. cholerae</em> can be identified by biochemical tests; serogroup and serotype can be assigned by testing with specific antibodies [<a href="#rid54">54</a>]. </p><p>During transport to a central laboratory from field settings, <em>V. cholerae</em> can persist in a number of standard transport media including Cary-Blair media. In addition, recovery of viable <em>V. cholerae</em> can be enhanced by enrichment in alkaline peptone water [<a href="#rid54">54</a>]. </p><p>In settings where cholera is a sporadic illness, the microbiology laboratory should be notified of suspicion for cholera so that appropriate selective media can be used; these media are not used routinely for stool culture.</p><p class="headingAnchor" id="H682183590"><span class="h3">Rapid tests and other tools</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen detection</strong> – Several rapid antigen detection-based tests are commercially available for diagnosis of cholera [<a href="#rid55">55</a>]. Antibody-based immunochromatographic dipstick assays (for stool or rectal swab) include Crystal VC (which detects presence of O1 or O139 antigen) and Cholkit (which detects the O1 antigen only). </p><p></p><p class="bulletIndent1">In one meta-analysis including 20 studies and 8 different commercial rapid tests, the combined sensitivity was 90 percent (95% CI, 86-93) and the specificity was 86 percent (95% CI, 81-90), relative to bacterial culture (the diagnostic gold standard); there was variation across individual studies [<a href="#rid55">55</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Molecular tests</strong> – Molecular testing f<em>or V. cholerae</em> is feasible; however, thus far practical use has been limited to epidemiologic research and surveillance [<a href="#rid56">56</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Darkfield microscopy</strong> − Darkfield microscopy of rice-water stools (at 400x magnification) can be used to evaluate for the presence of highly motile <em>Vibrios</em>, whose shooting star-like motion can be inhibited by the subsequent addition of specific antibodies [<a href="#rid57">57</a>]. Darkfield microscopy is highly specific for <em>V. cholerae</em> but lacks sufficient sensitivity to be used for routine diagnosis.</p><p></p><p class="headingAnchor" id="H609426450"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>A variety of pathogens can cause acute watery diarrhea  (<a class="graphic graphic_table graphicRef86525" href="/d/graphic/86525.html" rel="external">table 3</a> and <a class="graphic graphic_table graphicRef50975" href="/d/graphic/50975.html" rel="external">table 4</a>). </p><p>In resource-limited settings, rotavirus and cryptosporidium are frequent pathogens among infants and young children, whereas enterotoxigenic <em>Escherichia coli</em> predominates among older children and adults.</p><p class="headingAnchor" id="H534544460"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/109942.html" rel="external">"Society guideline links: Acute diarrhea in adults"</a> and  <a class="medical medical_society_guidelines" href="/d/html/115404.html" rel="external">"Society guideline links: Travel medicine"</a>.)</p><p class="headingAnchor" id="H690483856"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong> – Cholera is a life-threatening diarrheal illness caused by cholera toxin-producing strains of <em>Vibrio cholerae</em> (serogroups O1 and O139). (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – <em>V. cholerae</em> is transmitted via the fecal-oral route; this includes transmission within households or between close contacts, as well as outbreaks related to contaminated food and water. (See <a class="local">'Transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> – Each year, there are an estimated 3 million cases of diarrheal illness and approximately 100,000 deaths worldwide caused by <em>V. cholerae</em>; however, cholera is vastly underreported.<em> </em>Cholera occurs primarily in settings where there is inadequate access to clean water and sanitation; it occurs endemically as well as epidemically. (See <a class="local">'Endemic versus epidemic infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – <em>V. cholerae</em> infection is associated with a spectrum of manifestations ranging from asymptomatic intestinal colonization to severe diarrhea.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Incubation period</strong> – The typical incubation period is one to two days.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Gastrointestinal symptoms </strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Vomiting may begin before or after onset of diarrhea. Patients may have abdominal cramping but usually do not have frank abdominal pain. Fever is uncommon. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Severe cholera ("cholera gravis") is characterized by passage of profuse "rice-water" stool, a watery stool with flecks of mucous  (<a class="graphic graphic_picture graphicRef93210" href="/d/graphic/93210.html" rel="external">picture 1</a>). It typically has a fishy odor. The diarrhea is usually painless, without tenesmus. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Severe cholera is associated with rapid development of hypovolemic shock due to profound fluid and electrolyte losses, often within hours of the symptom onset. Manifestations of hypovolemia are summarized in the table  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 2</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>When to suspect cholera</strong> – Cholera is a potential cause of severe watery diarrhea (with or without vomiting), especially in patients who develop rapid and severe volume depletion  (<a class="graphic graphic_table graphicRef68271" href="/d/graphic/68271.html" rel="external">table 2</a>). </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Diagnostic evaluation </strong></p><p></p><p class="bulletIndent3"><span class="glyph">-</span>In most cases, cholera is diagnosed presumptively; however, there are no signs or symptoms that can unequivocally distinguish cholera from other infectious causes. </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>The diagnosis of cholera can be confirmed by isolation of <em>V. cholerae</em> from stool cultures performed on selective media. In settings where stool culture is not readily available, rapid tests such as stool dipsticks or darkfield microscopy can support the diagnosis.</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Chowdhury F, Ross AG, Islam MT, et al. Diagnosis, Management, and Future Control of Cholera. Clin Microbiol Rev 2022; 35:e0021121.</a></li><li><a class="nounderline abstract_t">Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous phage encoding cholera toxin. Science 1996; 272:1910.</a></li><li><a class="nounderline abstract_t">Lebens M, Karlsson SL, Källgård S, et al. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens. Vaccine 2011; 29:7505.</a></li><li><a class="nounderline abstract_t">Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 2011; 477:462.</a></li><li><a class="nounderline abstract_t">Waldor MK, Mekalanos JJ. Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype. J Infect Dis 1994; 170:278.</a></li><li><a class="nounderline abstract_t">Pruzzo C, Vezzulli L, Colwell RR. Global impact of Vibrio cholerae interactions with chitin. Environ Microbiol 2008; 10:1400.</a></li><li><a class="nounderline abstract_t">Levine MM, Kaper JB, Herrington D, et al. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet 1988; 2:467.</a></li><li><a class="nounderline abstract_t">Nelson EJ, Harris JB, Morris JG Jr, et al. Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat Rev Microbiol 2009; 7:693.</a></li><li><a class="nounderline abstract_t">Merrell DS, Butler SM, Qadri F, et al. Host-induced epidemic spread of the cholera bacterium. Nature 2002; 417:642.</a></li><li><a class="nounderline abstract_t">Hartley DM, Morris JG Jr, Smith DL. Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics? PLoS Med 2006; 3:e7.</a></li><li><a class="nounderline abstract_t">Richterman A, Sainvilien DR, Eberly L, Ivers LC. Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis. J Infect Dis 2018; 218:S154.</a></li><li><a class="nounderline abstract_t">O'Connor KA, Cartwright E, Loharikar A, et al. Risk factors early in the 2010 cholera epidemic, Haiti. Emerg Infect Dis 2011; 17:2136.</a></li><li><a class="nounderline abstract_t">Mohareb AM, Ivers LC. Disease and Famine as Weapons of War in Yemen. N Engl J Med 2019; 380:109.</a></li><li><a class="nounderline abstract_t">Rabbani GH, Greenough WB 3rd. Food as a vehicle of transmission of cholera. J Diarrhoeal Dis Res 1999; 17:1.</a></li><li><a class="nounderline abstract_t">Harris JB, LaRocque RC, Chowdhury F, et al. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis 2008; 2:e221.</a></li><li><a class="nounderline abstract_t">Glass RI, Holmgren J, Haley CE, et al. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am J Epidemiol 1985; 121:791.</a></li><li><a class="nounderline abstract_t">Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun 2005; 73:7422.</a></li><li><a class="nounderline abstract_t">Kuhlmann FM, Santhanam S, Kumar P, et al. Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera. Am J Trop Med Hyg 2016; 95:440.</a></li><li><a class="nounderline abstract_t">Karlsson EK, Harris JB, Tabrizi S, et al. Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med 2013; 5:192ra86.</a></li><li><a class="nounderline abstract_t">Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 2011; 34:1269.</a></li><li><a class="nounderline abstract_t">Levine MM, Black RE, Clements ML, et al. Duration of infection-derived immunity to cholera. J Infect Dis 1981; 143:818.</a></li><li><a class="nounderline abstract_t">Glass RI, Becker S, Huq MI, et al. Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol 1982; 116:959.</a></li><li><a class="nounderline abstract_t">Ali M, Emch M, Park JK, et al. Natural cholera infection-derived immunity in an endemic setting. J Infect Dis 2011; 204:912.</a></li><li><a class="nounderline abstract_t">Glass RI, Svennerholm AM, Stoll BJ, et al. Protection against cholera in breast-fed children by antibodies in breast milk. N Engl J Med 1983; 308:1389.</a></li><li><a class="nounderline abstract_t">Molla AM, Rahman M, Sarker SA, et al. Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V. cholerae in children. J Pediatr 1981; 98:835.</a></li><li><a class="nounderline abstract_t">Ali M, Nelson AR, Lopez AL, Sack DA. Updated global burden of cholera in endemic countries. PLoS Negl Trop Dis 2015; 9:e0003832.</a></li><li class="breakAll">WHO cholera dashboard. https://worldhealthorg.shinyapps.io/page2cholera_maps/ (Accessed on June 16, 2023).</li><li><a class="nounderline abstract_t">Harris JB, LaRocque RC, Qadri F, et al. Cholera. Lancet 2012; 379:2466.</a></li><li class="breakAll">Pan American Health Organization. Epidemiological Update, Cholera. December 5, 2013. http://www.paho.org/hq/index.php?option=com_docman&amp;task=doc_view&amp;gid=23750+&amp;Itemid=999999&amp;lang=en (Accessed on December 05, 2013).</li><li><a class="nounderline abstract_t">Newton AE, Heiman KE, Schmitz A, et al. Cholera in United States associated with epidemic in Hispaniola. Emerg Infect Dis 2011; 17:2166.</a></li><li><a class="nounderline abstract_t">Koelle K, Rodó X, Pascual M, et al. Refractory periods and climate forcing in cholera dynamics. Nature 2005; 436:696.</a></li><li><a class="nounderline abstract_t">Deen JL, von Seidlein L, Sur D, et al. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis 2008; 2:e173.</a></li><li><a class="nounderline abstract_t">Chin CS, Sorenson J, Harris JB, et al. The origin of the Haitian cholera outbreak strain. N Engl J Med 2011; 364:33.</a></li><li class="breakAll">Cravioto A, Lanata C, Lantagne D and Nair GB. Final Report of the Independent Panel of Experts on the Cholera Outbreak in Haiti. United Nations, 2011.</li><li><a class="nounderline abstract_t">Barzilay EJ, Schaad N, Magloire R, et al. Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med 2013; 368:599.</a></li><li><a class="nounderline abstract_t">Vega Ocasio D, Juin S, Berendes D, et al. Cholera Outbreak - Haiti, September 2022-January 2023. MMWR Morb Mortal Wkly Rep 2023; 72:21.</a></li><li><a class="nounderline abstract_t">Daniels JP. Cholera surges in Haiti. Lancet 2022; 400:1913.</a></li><li class="breakAll">http://www.who.int/mediacentre/news/releases/2017/cholera-yemen-mark/en/.</li><li class="breakAll">World Health Organization. Cholera – Global situation, 16 December 2022. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON426 (Accessed on December 20, 2022).</li><li><a class="nounderline abstract_t">Harris JB, Larocque RC, Charles RC, et al. Cholera's western front. Lancet 2010; 376:1961.</a></li><li><a class="nounderline abstract_t">Reyburn R, Deen JL, Grais RF, et al. The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis 2011; 5:e952.</a></li><li><a class="nounderline abstract_t">Weil AA, Khan AI, Chowdhury F, et al. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis 2009; 49:1473.</a></li><li><a class="nounderline abstract_t">Cash RA, Music SI, Libonati JP, et al. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J Infect Dis 1974; 129:45.</a></li><li><a class="nounderline abstract_t">Hornick RB, Music SI, Wenzel R, et al. The Broad Street pump revisited: response of volunteers to ingested cholera vibrios. Bull N Y Acad Med 1971; 47:1181.</a></li><li><a class="nounderline abstract_t">Oseasohn R, Ahmad S, Islam MA, Rahman AS. Clinical and bacteriological findings among families of cholera patients. Lancet 1966; 1:340.</a></li><li><a class="nounderline abstract_t">Harris JB, Ivers LC, Ferraro MJ. Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea. N Engl J Med 2011; 364:2452.</a></li><li><a class="nounderline abstract_t">Hirschhorn N, Kinzie JL, Sachar DB, et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med 1968; 279:176.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: outbreak of cholera ---Haiti, 2010. MMWR Morb Mortal Wkly Rep 2010; 59:1586.</a></li><li><a class="nounderline abstract_t">Ryan ET, Dhar U, Khan WA, et al. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg 2000; 63:12.</a></li><li><a class="nounderline abstract_t">Ciglenecki I, Bichet M, Tena J, et al. Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti. PLoS Negl Trop Dis 2013; 7:e2368.</a></li><li><a class="nounderline abstract_t">Ganesan D, Gupta SS, Legros D. Cholera surveillance and estimation of burden of cholera. Vaccine 2020; 38 Suppl 1:A13.</a></li><li class="breakAll">World Health Organization. The treatment of diarrhoea, a manual for physicians and other senior health workers. 4th revision. WHO/FCH/CAH/05.1. Geneva: World Health Organization, 2005. https://apps.who.int/iris/handle/10665/43209 (Accessed on June 16, 2023).</li><li class="breakAll">World Health Organization. Cholera Outbreak Toolbox. https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/cholera-outbreak-toolbox (Accessed on October 16, 2023).</li><li class="breakAll">World Health Organization: Department of Communicable Disease Surveillance and Response. Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial Pathogens of Public Health Importance in the Developing World.  2003:103.</li><li><a class="nounderline abstract_t">Muzembo BA, Kitahara K, Ohno A, et al. Cholera Rapid Diagnostic Tests for the Detection of Vibrio cholerae O1: An Updated Meta-Analysis. Diagnostics (Basel) 2021; 11.</a></li><li><a class="nounderline abstract_t">Taniuchi M, Islam K, Sayeed MA, et al. Etiology of Diarrhea Requiring Hospitalization in Bangladesh by Quantitative Polymerase Chain Reaction, 2014-2018. Clin Infect Dis 2021; 73:e2493.</a></li><li><a class="nounderline abstract_t">BENENSON AS, ISLAM MR, GREENOUGH WB 3rd. RAPID IDENTIFICATION OF VIBRIO CHOLERAE BY DARKFIELD MICROSCOPY. Bull World Health Organ 1964; 30:827.</a></li></ol></div><div id="topicVersionRevision">Topic 2704 Version 41.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35726607" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Diagnosis, Management, and Future Control of Cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8658163" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Lysogenic conversion by a filamentous phage encoding cholera toxin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21807059" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21866102" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Evidence for several waves of global transmission in the seventh cholera pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035010" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18312392" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Global impact of Vibrio cholerae interactions with chitin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2900401" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19756008" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Cholera transmission: the host, pathogen and bacteriophage dynamic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12050664" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Host-induced epidemic spread of the cholera bacterium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16318414" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30137536" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Individual and Household Risk Factors for Symptomatic Cholera Infection: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22099118" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Risk factors early in the 2010 cholera epidemic, Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30462588" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Disease and Famine as Weapons of War in Yemen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10892490" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Food as a vehicle of transmission of cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18398491" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4014172" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Predisposition for cholera of individuals with O blood group. Possible evolutionary significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16239542" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27162272" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Blood Group O-Dependent Cellular Responses to Cholera Toxin: Parallel Clinical and Epidemiological Links to Severe Cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23825302" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Natural selection in a bangladeshi population from the cholera-endemic ganges river delta.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21999643" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7252264" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Duration of infection-derived immunity to cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7148820" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Endemic cholera in rural Bangladesh, 1966-1980.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21849288" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Natural cholera infection-derived immunity in an endemic setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6843632" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Protection against cholera in breast-fed children by antibodies in breast milk.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6262471" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Stool electrolyte content and purging rates in diarrhea caused by rotavirus, enterotoxigenic E. coli, and V. cholerae in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26043000" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Updated global burden of cholera in endemic countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26043000" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Updated global burden of cholera in endemic countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22748592" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22748592" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22204035" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Cholera in United States associated with epidemic in Hispaniola.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16079845" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Refractory periods and climate forcing in cholera dynamics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18299707" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21142692" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The origin of the Haitian cholera outbreak strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21142692" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The origin of the Haitian cholera outbreak strain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23301694" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Cholera surveillance during the Haiti epidemic--the first 2 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36634024" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Cholera Outbreak - Haiti, September 2022-January 2023.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36463898" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Cholera surges in Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36463898" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Cholera surges in Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36463898" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cholera surges in Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21112083" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cholera's western front.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21283614" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The case for reactive mass oral cholera vaccinations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19842974" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical outcomes in household contacts of patients with cholera in Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4809112" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5286453" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The Broad Street pump revisited: response of volunteers to ingested cholera vibrios.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4159477" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical and bacteriological findings among families of cholera patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21696312" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4968807" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21150867" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Update: outbreak of cholera ---Haiti, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11357989" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23967361" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Cholera in pregnancy: outcomes from a specialized cholera treatment unit for pregnant women in Léogâne, Haiti.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31326254" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Cholera surveillance and estimation of burden of cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31326254" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Cholera surveillance and estimation of burden of cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31326254" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Cholera surveillance and estimation of burden of cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31326254" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cholera surveillance and estimation of burden of cholera.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34829444" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Cholera Rapid Diagnostic Tests for the Detection of Vibrio cholerae O1: An Updated Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32592580" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Etiology of Diarrhea Requiring Hospitalization in Bangladesh by Quantitative Polymerase Chain Reaction, 2014-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14215188" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : RAPID IDENTIFICATION OF VIBRIO CHOLERAE BY DARKFIELD MICROSCOPY.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
